2025年4月8日 周二
首页 > 按月查看>2020年第3月 >273-276
PDF 导出
血浆致动脉硬化指数在心血管疾病中的应用进展
作者:
作者单位:

(川北医学院医学检验系 川北医学院附属医院检验科,四川省南充市 637000)

作者简介:

陈明丹,硕士研究生,研究方向为自身免疫性疾病的诊断,E-mail为516662670@qq.com。通信作者邢艳,博士,教授,硕士研究生导师,研究方向为自身免疫性疾病发病机制及实验诊断,E-mail为381679399@qq.com。


Progress on the application of atherogenic index of plasma in cardiovascular diseases
Author:
Affiliation:

Department of Medical Laboratory, North Sichuan Medical College & Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, China)

  • 摘要
    • | |
  • 访问统计
    • |
  • 参考文献
    • |
  • 相似文献
    • | |
    摘要:

    心血管疾病(CVD)是一种严重威胁人类健康的疾病,如何较早发现并预防心血管事件的发生,是我们急需解决的问题。血浆致动脉硬化指数(AIP)是最近几年提出的CVD的独立预测指标,由血浆甘油三酯(TG)和高密度脂蛋白胆固醇(HDLC)比值的对数转换得出,即log[TG/HDLC]。相比既往单一指标而言,AIP更能综合反映血脂代谢水平,对于疾病的临床诊断及治疗监测意义重大。现就AIP在CVD中的应用进展予以综述。

    Abstract:

    Cardiovascular disease (CVD) is a serious threat to human health. It is an urgent problem for clinicians to early detect and prevent the occurrence of cardiovascular events. Atherogenic index of plasma (AIP) is an independent predictor of CVD proposed in recent years. It is derived from the logarithm conversion of the ratio of triglyceride (TG) to high density lipoprotein cholesterol (HDLC), i.e., log[TG/HDLC]. Compared with the previous single index, AIP can more comprehensively reflect the level of lipid metabolism, which is of great significance for clinical diagnosis and treatment monitoring of diseases. This article reviews the application of AIP in CVD.

    参考文献
    [1] Chang Y, Li Y, Guo X, et al.The association of ideal cardiovascular health and atherogenic index of plasma in rural population:A cross-sectional study from Northeast China.Int J Environ Res Public Health, 6,3(10):1027.
    [2] Dobiásová M, Frohlich J.The plasma parameter log (TG/HDL-C) as an atherogenic index:correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)).Clin Biochem, 1,4(7):583-588.
    [3] Zhan Y, Xu T, Tan X.Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome:atherogenic index of plasma, neutrophil-lymphocyte ratio.BMC Cardiovasc Disord, 6,6(1):96.
    [4] Dobiásová M.AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk:from research to practice.Vnitr Lek, 6,2(1):64-71.
    [5] Bo MS, Cheah WL, Lwin S, et al.Understanding the relationship between atherogenic index of plasma and cardiovascular disease risk factors among staff of an university in Malaysia.J Nutr Metab, 8,8:7027624.
    [6] Bays HE, González-Campoy JM, Bray GA, et al.Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.Expert Rev Cardiovasc Ther, 8,6(3):343-368.
    [7] Bays HE, Toth PP, Kris-Etherton PM, et al.Obesity, adiposity, and dyslipidemia:A consensus statement from the National Lipid Association.J Clin Lipidol, 3,7(4):304-383.
    [8] Nishide R, Ando M, Funabashi H, et al.Association of serum hs-CRP and lipids with obesity in school children in a 12-month follow-up study in Japan.Environ Health Prev Med, 5,0(2):116-122.
    [9] Bora K, Pathak MS, Borah P, et al.Association of the apolipoprotein A-I gene polymorphisms with cardiovascular disease risk factors and atherogenic indices in patients from Assam, Northeast India.Balkan J Med Genet, 7,0(1):59-70.
    [10] Zhu X, Yu L, Zhou H, et al.Atherogenic index of plasma is a novel and better biomarker associated with obesity:a population-based cross-sectional study in China.Lipids Health Dis, 8,7(1):37.
    [11] Goel S, Garg PK, Malhotra V, et al.Dyslipidemia in type II diabetes mellitus--An assessment of the main lipoprotein abnormalities.Bangladesh J Med Sci, 6,5(1):99-102.
    [12] Vergès B.Pathophysiology of diabetic dyslipidaemia:where are we?.Diabetologia, 5,8(5):886-899.
    [13] Schofield JD, Liu Y, Rao-Balakrishna P, et al.Diabetes dyslipidemia.Diabetes Ther, 6,7(2):203-219.
    [14] Li JJ.Inflammation in coronary artery diseases.Chin Med J (Engl), 1,4(21):3568-3575.
    [15] 薛超, 刘文玲, 孙艺红, 等.炎症及免疫指标对类风湿关节炎患者血脂的影响分析.中华心血管病杂志, 1,9(10):941-945.
    [16] Pourfarzam M, Zadhoush F, Sadeghi M.The difference in correlation between insulin resistance index and chronic inflammation in type 2 diabetes with and without metabolic syndrome.Adv Biomed Res, 6,5:153.
    [17] Balta S, Aparci M, Ozturk C, et al.Carotid intima media thickness and subclinical early atherosclerosis.Int J Cardiol, 6,3:1146.
    [18] Jeurissen MLJ, Walenbergh SMA, Houben T, et al.Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr－/－ mice.Atherosclerosis, 6,5:59-65.
    [19] Uslu AU, Kucuk A, Balta S, et al.The relation between ischemia modified albumin levels and carotid intima media thickness in patients with rheumatoid arthritis.Int J Rheum Dis, 9,2(1):32-37.
    [20] Uslu AU, Kucuk A, Icli A, et al.Plasma atherogenic index is an independent indicator of subclinical atherosclerosis in systemic lupus erythematosus.Eurasian J Med, 7,9(3):193-197.
    [21] Cure E, Icli A, Uslu AU, et al.Atherogenic index of plasma:a useful marker for subclinical atherosclerosis in ankylosing spondylitis.Clin Rheumatol, 8,7(5):1273-1280.
    [22] Icli A, Cure E, Uslu AU, et al.The relationship between atherogenic index and carotid artery atherosclerosis in familial mediterranean fever.Angiology, 7,8(4):315-321.
    [23] Cai G, Shi G, Xue S, et al.The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population.Medicine, 7,6(37):e8058.
    [24] Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, et al.Atherogenic index of plasma (AIP):A marker of cardiovascular disease.Med J Islam Repub Iran, 5,9(1):240.
    [25] Ni W, Zhou Z, Liu T, et al.Gender-and lesion number-dependent difference in "atherogenic index of plasma" in Chinese people with coronary heart disease.Sci Rep, 7,7(1):13207.
    [26] Guelker JE, Bufe A, Blockhaus C, et al.The atherogenic index of plasma and its impact on recanalization of chronic total occlusion.Cardiol J, 2018, doi:10.5603/CJ.a2018.0064.
    [27] Wan K, Zhao J, Huang H, et al.The association between triglyceride/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization.PLoS One, 5,0(4):e0123521.
    [28] Edwards MK, Loprinzi PD.Physical activity and diet on atherogenic index of plasma among adults in the United States:mediation considerations by central adiposity.Eur J Clin Nutr, 8,2(6):826-831.
    [29] Króliczewska B, Mista D, Ziarnik A, et al.The effects of seed from Linum usitatissimum, cultivar with increased phenylpropanoid compounds and hydrolysable tannin in a high cholesterol-fed rabbit.Lipids Health Dis, 8,7(1):76.
    相似文献
    引证文献
引用本文

陈明丹,邢艳.血浆致动脉硬化指数在心血管疾病中的应用进展[J].中国动脉硬化杂志,2020,28(3):273~276.

复制
分享
文章指标
  • 点击次数:1896
  • 下载次数: 1044
历史
  • 收稿日期:2019-04-29
  • 最后修改日期:2019-06-06
  • 在线发布日期: 2020-01-20

您是本站第 4762669 访问者

邮编：421001 传真：0734-8160523

电话：0734-8160765 E-mail：dmzzbjb@163.net

中国动脉硬化杂志 ® 2025 网站版权所有